Question 1

What is the catalog number for TNFSF4/OX40L/CD252 (amlitelimab) discontinued. See 591663?

Accepted Answer

The catalog number for TNFSF4/OX40L/CD252 (amlitelimab) discontinued. See 591663 is 048069.

Question 2

What sizes are available for TNFSF4/OX40L/CD252 (amlitelimab) discontinued. See 591663?

Accepted Answer

TNFSF4/OX40L/CD252 (amlitelimab) discontinued. See 591663 is available in the following size(s): 100 µg.

Question 3

Is TNFSF4/OX40L/CD252 (amlitelimab) discontinued. See 591663 in stock?

Accepted Answer

TNFSF4/OX40L/CD252 (amlitelimab) discontinued. See 591663 is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

Is this product tested for endotoxin levels?

Accepted Answer

Endotoxin testing status is noted on the datasheet where applicable, particularly for recombinant proteins intended for cell-based or functional assays. If this isn’t listed and you need confirmation, contact support with the catalogue number.

Question 5

Can I request additional validation data, such as western blot images, for this product?

Accepted Answer

Additional data may be available on request. Contact our technical support team with the catalogue number and we’ll check what supporting documentation the supplier can provide.

Question 6

What documentation should I request if this product is used for a regulated or intellectual-property-sensitive application?

Accepted Answer

If the product is subject to intellectual property protections, we’ll advise on any MTA or usage restrictions before shipping. Let us know your intended end use so we can confirm what’s required upfront.

TNFSF4/OX40L/CD252 (amlitelimab) discontinued. See 591663

Product Specifications

Clonality

Frequently Asked Questions

Explore Other Products

Ep-CAM / CD326 (VU-1D9), CF594 conjugate, 0.1mg/mL

CD44 Standard (DF1485), CF680 conjugate, 0.1mg/mL

CD16 (C16/1045), CF488A conjugate, 0.1mg/mL

CD5 (Cris-1), CF640R conjugate, 0.1mg/mL

CD45RO (UCHL-1), CF740 conjugate, 0.1mg/mL

Napsin-A (NAPSA/1238), CF640R conjugate, 0.1mg/mL